📰 Sciences Profile News
Sciences Profile News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sciences Profile. Real-time updates on events, politics, business and more.
May 27, 2024
1492 Capital Management LLC lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 0.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 84,154 shares of the medical research company’s stock after selling 362 shares during […]
April 27, 2024
Motley Fool Asset Management LLC lessened its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,931 shares of the medical research company’s stock after selling 310 shares during the quarter. Motley […]
April 27, 2024
Motley Fool Asset Management LLC cut its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,931 shares of the medical research company’s stock after selling 310 shares during the quarter. […]
April 21, 2024
Hussman Strategic Advisors Inc. grew its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 400.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,500 shares of the medical research company’s stock after buying an additional 25,200 shares […]
April 12, 2024
Impax Asset Management Group plc trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,945 shares of the medical research company’s stock after selling 413 shares during […]
April 7, 2024
Silvant Capital Management LLC reduced its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 13.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,119 shares of the medical research company’s stock after selling 2,181 shares during the period. Silvant […]
April 2, 2024
Perfromance Wealth Partners LLC reduced its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 10.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,737 shares of the medical research company’s stock after selling 565 shares during the period. […]
February 16, 2024
Rhenman & Partners Asset Management AB trimmed its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 8.6% in the third quarter, Holdings Channel.com reports. The firm owned 160,000 shares of the medical research company’s stock after selling 15,000 shares during the quarter. Rhenman & Partners Asset Management AB’s holdings in Exact Sciences were […]
February 11, 2024
Biondo Investment Advisors LLC boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 2.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 112,696 shares of the medical research company’s stock after buying an additional 3,103 shares during the […]
February 8, 2024
Swiss National Bank trimmed its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.8% during the third quarter, HoldingsChannel.com reports. The fund owned 580,280 shares of the medical research company’s stock after selling 63,200 shares during the quarter. Swiss National Bank’s holdings in Exact Sciences were worth $39,587,000 at the end of the […]